GlassScriptPhysician profile
Rabab Mohsin
NPI 1316172067
$3,270.28
in general payments reported to CMS, 2019-2025
20 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $490 · 2020: $334 · 2021: $499 · 2022: $690 · 2023: $663 · 2024: $386 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,257.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $666.88 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx, Confirm Rx |
| Boston Scientific Corporation | $577.35 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Novartis Pharmaceuticals Corporation | $449.88 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $378.81 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $229.46 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $224.31 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.36 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $112.94 | 2021-2023 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $93.32 | 2020-2024 | Farxiga |
| Amgen INC. | $89.66 | 2020-2025 | Repatha |
| Medtronic Vascular, INC. | $73.11 | 2019 | |
| Sanofi-Aventis U.S. LLC | $48.88 | 2019-2022 | |
| Infobionic, INC | $45.09 | 2020 | |
| Heartflow, INC. | $33.23 | 2022 | |
| Ge Healthcare | $31.21 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $29.24 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Esperion Therapeutics, INC. | $21.00 | 2021 | |
| Kestra Medical Technology Services, INC. | $19.12 | 2024 | Assure Wcd |
| Medtronic, INC. | $16.10 | 2023 | Azure Xt Dr Mri Surescan |
| Pfizer INC. | $12.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabab Mohsin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.